The clinical applications of colony-stimulating factors in acquired immunodeficiency syndrome.
Scadden
D T
DT
Harvard Medical School, Division of Hematology/Oncology, Boston, MA.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000188:drug therapy / Q000628:therapy*; D000740:Anemia / Q000150:complications / Q000628:therapy; D000998:Antiviral Agents / Q000627:therapeutic use; D003115:Colony-Stimulating Factors / Q000494:pharmacology / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D004341:Drug Evaluation; D015497:HIV-1 / Q000187:drug effects / Q000502:physiology; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D016898:Interferon-alpha / Q000627:therapeutic use; D007970:Leukopenia / Q000150:complications / Q000628:therapy; D011994:Recombinant Proteins / Q000494:pharmacology / Q000627:therapeutic use; D013921:Thrombocytopenia / Q000150:complications / Q000628:therapy; D014779:Virus Replication / Q000187:drug effects
D000998:Antiviral Agents; D003115:Colony-Stimulating Factors; D016298:Hematopoietic Cell Growth Factors; D007155:Immunologic Factors; D016898:Interferon-alpha; D011994:Recombinant Proteins